These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24325117)
1. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis]. Lin H; Liang Y; Wang Y; Cen XM; Yin G; Xie QB Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):805-9. PubMed ID: 24325117 [TBL] [Abstract][Full Text] [Related]
3. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858 [TBL] [Abstract][Full Text] [Related]
4. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973 [TBL] [Abstract][Full Text] [Related]
5. [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy]. Li R; Li XP; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Zhang H Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2335-8. PubMed ID: 23158563 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528 [TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China. Li T; Tang ZY; Zhang QB; Xiao FN; Jian GL; Xie Y; Guo JW; Qing YF Curr Rheumatol Rev; 2023; 19(4):455-462. PubMed ID: 37005523 [TBL] [Abstract][Full Text] [Related]
8. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis]. Wang PZ; Guan JL; Han XH Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800 [TBL] [Abstract][Full Text] [Related]
9. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240 [TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351 [TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis. Takada T; Aoki A; Asakawa K; Sakagami T; Moriyama H; Narita I; Sato S Respir Med; 2015 Sep; 109(9):1174-80. PubMed ID: 26187000 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease. Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808 [TBL] [Abstract][Full Text] [Related]
13. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD. Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease in polymyositis and dermatomyositis. Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835 [TBL] [Abstract][Full Text] [Related]
15. [Risk Factors of Respiratory Failure in the Dermatomyositis Patients with Interstitial Lung Disease]. Zhang SH; Peng Y; Xie QB; Yin G; Yan B Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):188-194. PubMed ID: 29737058 [TBL] [Abstract][Full Text] [Related]
16. An approach to the development of interstitial lung disease in dermatomyositis: a study of 230 cases in China. Wu H; Geng D; Xu J J Int Med Res; 2013 Apr; 41(2):493-501. PubMed ID: 23569020 [TBL] [Abstract][Full Text] [Related]
17. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Oga T; Chin K; Nagai S; Mimori T; Mishima M Respir Med; 2011 Sep; 105(9):1380-7. PubMed ID: 21632230 [TBL] [Abstract][Full Text] [Related]
18. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis]. Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of HRCT in myositis-associated interstitial lung disease. Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Aihara K; Ikezoe K; Watanabe K; Taguchi Y; Hatta K; Oga T; Chin K; Nagai S; Mimori T; Mishima M Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]